首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 生物科技 > 世界的基因工學市場
產業/市場分類
生物科技 (1574)
分子標靶治療學 (131)
生技設備 (354)
生物材料 (53)
生物標記 (155)
以基因為基之藥物開發 (202)
再生醫學 (119)
抗體和免疫 (189)
個人化醫學 (51)
基因治療學和RNAi (102)
市場調查報告書

世界的基因工學市場

Genetic Engineering

出版商 Global Industry Analysts, Inc.
出版日期 2009年10月 商品編碼 101186
內容資訊 英文 Pages: 63
價格
本報告書已不再販售

本報告已在2012年02月24日停止出版。

更改為出版

Genetic Engineering
出版日期 : 2012年01月
商品編碼: 232197

簡介

報告內容包括:世界的基因工學市場相關分析、現在的技術和應用動向、基因改造作物相關議論、課題和將來的研究開發動向等統整。內容概要如下:

第1章 業界的概要

  • 基因工學
  • 基因改造作物的展開和進步
  • 世界上所被認知的基因改造作物
  • 開發中國家的基因改造作物的栽培
  • 價格上漲和食物不足,讓生物工程帶來魅力
  • 導入基因改造作物的課題
  • 生物工程的管制對策阻害作物的栽培
  • 政府仍未捨棄基因改造作物的希望
  • 美國:基因改造作物的最大生產國
  • 主要市場參與者

第2章 市場動向

  • 世界的食物需求促進基因改造作物的需求
  • 基因工學﹕食物危機的解決對策
  • 對健康有害還是有益:基因改造作物神話的崩壞
  • 受惠於基因工學技術的食品部門以外的領域
  • 基因工學和酵素

第3章 課題和擔憂事項

  • 基因改造作物相關問題在今後仍然持續
  • 站在承認或是反對基因改造作物分歧的國家
  • 為能統整基因改造作物相關議論的世界議程設定

第4章 地域別動向

  • 美國:成長大豆、小麥作物
  • 英國:政府針對基因改造作物的提案
  • 西班牙:基因改造的小麥農園增加
  • 中國:生物承包市場
  • 印度:棉花栽培
  • 澳洲:收益高的基因改造作物
  • 馬來西亞:生物工程
  • 南非:生物工程作物的栽培

第5章 基因工學:概要

  • 概念
  • 分子基本資訊:基因
  • 染色體組:資訊網
  • 基因工學的發展
  • 基因染色體計畫
  • 基因療法
  • 人體基因工學
  • 動物基因工學
  • 農業上生物工程的使命
  • 基因改造食品
  • 基因工學和食品加工
  • 基因改造作物管制環境
  • 特許:概要

第6章 基因療法

  • 對基因療法未來發展帶來影響的因素
  • 阻害因素
  • 商業化
  • 標的疾病和活躍的企業
  • 在歐洲及美國的基因療法業界

第7章 研究開發

第8章 合併-收購

第9章 近年來業界的動向

第10章 產品/服務上市

目錄

Abstract

The global outlook series on Genetic Engineering provides a collection of market briefs and concise summaries of research findings. The report offers a bird' s eye view of the industry, highlights latest developments, and discusses demand drivers, issues and concerns, and regulatory environment. Discussion on the industry' s most noteworthy regional market, the US, is amply detailed with unbiased research commentary to provide the reader a rudimentary understanding of the prevailing market climate. The report also provides select data on regional markets. Also included is an indexed, easy-to-refer, fact-finder directory listing the addresses, and contact details of 169 companies active in the market.

Table of Contents

1. INDUSTRY OVERVIEW

  • Genetic Engineering: A Prelude
  • The Evolution and Progress of GM Crops
  • GM Crops Gain Global Acceptance
  • GM Cultivation Gains Prominence in Developing Nations
  • Rising Prices, Food Shortage Make Biotech Grains Attractive
  • Challenges to GM Crops Adoption
  • Biotech Regulatory Measures Hinder Crop Domestication
  • Governments Not to Give Up on GM Hope
  • US - The Largest Producer of GM Crops
  • Major Market Participants

2. MARKET DYNAMICS

  • Global Food Demand to Drive Need for GM Crops
  • Genetic Engineering - A Solution for Food Crisis!
  • Harmful or Healthy: Breaking The Myth About GM Crops
  • Non-food Sectors to Benefit from GE Technology
  • Genetic Engineering and Enzymes
  • GE to Help Starch and Sugar Processing Enzyme Market
  • GE to Drive Demand for Bakery Enzymes

3. ISSUES AND CONCERNS

  • The GM Food Issue Continues
  • Nations at Crossroads to Accept or Object GE Crops
  • Nations Set Global Agenda to Settle GM Crop Controversies

4. REGIONAL TRENDS

  • US Soybean and Corn Crop to Witness Robust Growth
  • GMO Crops' Future Hinges on Co-Existence Measures in EU
  • UK Government' s GM Crops Proposal Faces Rebuff
  • Spanish Transgenic Corn Plantation Increases
  • Chinese Biopharmaceutical Market to Continue its Growth Spurt
  • Government to Support Biopharmaceutical Innovation
  • India - The Leading Cultivator of Bt Cotton
  • India Ousts China in Bt Cotton Cultivation
  • GM Crops to Earn Good Returns for Australia
  • Biotechnology - A Boon for Agriculture in Malaysia
  • Biotech Crops Cultivation Zooms in South Africa

5. GENETIC ENGINEERING: AN OVERVIEW

  • The Concept...
  • Molecular Basics - The Gene
  • Genome - The Information Pool
  • Evolution of Genetic Engineering
  • Historical Developments in Genetic Engineering:
  • The Human Genome Project
  • Significant Events in the Past
  • Gene Therapy
  • Types of Gene Therapy
  • Monogenic Gene Therapy
  • Suicide Gene Therapy
  • Antisense Gene Therapy
  • Human Genetic Engineering
  • Genetic Engineering in Animals
  • Role of Biotechnology in Agriculture
  • Insect Resistant Crops Vs. Herbicide Tolerant Crops
  • Genetically Modified Foods
  • GM Food Faces Worldwide Criticism During Initial Years
  • Benefits of Genetically Modified Foods
  • Pest Resistance
  • Cold Tolerance
  • Herbicide Tolerance
  • Drought and Salinity Tolerance
  • Disease Resistance
  • Phytoremediation
  • Nutrition
  • Pharmaceuticals
  • Negative Impacts of GM Foods
  • Possibility of Crosspollination
  • Decreased Pesticides Effectiveness
  • Unintentional Destruction of Other Species
  • Health Concerns Related to GM Foods
  • Cost Concerns Related to GM Foods
  • Genetic Engineering and Food Processing
  • Genetic Engineering and Regulatory Environment
  • Patents - An Overview

6. GENE THERAPY - A REVIEW

  • Factors Influencing Gene Therapy' s Future Development
  • Human Genome Analysis
  • Gene Therapy - The Next Generation Cardiovascular Therapy
  • Public Support for Gene Therapy
  • RNAi Bode Bright Prospects
  • Factors Hampering Gene Therapy FutureDevelopment
  • Stringent US and European Regulatory Laws Prolongs Gene Therapy Development
  • Identifying Genetic Fault
  • Immune Response
  • Delivering Genetic Materials into Patient Cells
  • Multigene Disorders
  • Side Effects
  • Push Towards Germline Gene Transfer
  • Technical Limitations
  • Commercialization: A Road Uphill
  • Time Line in Gene Therapy Drug Development
    • Table 1: Gene Therapy Clinical Trials (2007): Percentage Breakdown by Geographic Region for the US, Europe, Canada, Japan and Rest of World
    • Table 2: Gene Therapy Clinical Trials Worldwide (2007): A Split by Development Phase
  • Various Gene Therapy Products Under Development (2007)
  • Target Diseases and Players Involved
  • Key Players by Application Area
    • Table 3: Gene Therapy Clinical Trials Worldwide (2007): Percentage Breakdown by Disease/ Application Area for Cancer, Heart Disease, Monogenic Diseases, Infectious Diseases and Others
    • Table 4: Gene Therapy Clinical Trials Worldwide (2007):Percentage Breakdown by Gene Type Transferred for Antigen, Cytokine, Tumor Suppressor, Growth Factor, Suicide, Deficiency and Others
    • Table 5: Gene Therapy Clinical Trials Worldwide (2007): Percentage Breakdown by Vector Type for Adenovirus, Retrovirus, Naked/Plasmid DNA, Lipofection, Vaccinia Virus, Poxvirus, Adeno- associated Virus, and Others
  • Gene Therapy Industry in Europe and the US - A Comparison

7. RESEARCH AND DEVELOPMENT

  • Anti-Clotting Drug from GE Goats to Win Approval
  • British Midlands University to Reveal Genetic Code of Bacterium Causing
  • Hospital Acquired Infection
  • Genetically Engineered BMPs to Facilitate Bone Formation in Orthopedic Surgeries
  • GE Finds Application in Obesity Control
  • Trubion Develops Advanced mAbs
  • New Study Reveals microRNA' s Role in Heart Failure
  • Cell-based Assays to Aid in Early Drug Discovery
  • Inhibition of SHIP Gene to Minimize Risk in Stem Cell Transplants
  • Drug Discovery to Employ Chemical Genetics
  • GE to Aid in the Discovery of New Enzyme Sources
  • Demand for Lactose-Free Products Boosts Enzymes Applications Market

8. MERGERS & ACQUISITIONS

  • RJH Industries Acquires Philippines Royal Oil
  • Monsanto Takes Over Aly Participacoes
  • Monsanto Acquires De Ruiter Seeds Group
  • Lydall Announces Acquisition of DSM Solutech
  • Biotie Completes Acquisition of elbion
  • Pfizer Animal Health Acquires Catapult Genetics
  • Monsanto Completes Marmot Acquisition
  • BioEnergy Takes Over Assets of OmniGene Bioproducts
  • BRAIN Takes Over Industrial Biotech Assets of MerLion Pharmaceuticals
  • MTS Health Investors Acquires DNA Diagnostic Center
  • Bayer HealthCare Takes Over Direvo Biotech
  • QIAGEN Completes Acquisition of Corbett Life Science
  • ChemVentures to Acquire BioFocus DPI Chemistry Facility
  • Nanobac Pharmaceuticals to Take Over DNAPrint Genomics
  • GlaxoSmithKline to Take Over Genelabs Technologies
  • Invitrogen Merges with Applied Biosystems
  • NitroMed Enters into Definitive Merger Agreement with Archemix
  • Monsanto Completes Acquisition of Delta & Pine Land
  • Inverness Medical Innovations Acquires Biosite
  • Avesta Biotherapeutics Takes Over Siegfried Biologics
  • Entelos Takes Over Iconix Biosciences
  • Illumina Takes Over Solexa
  • Celera Group Acquires Atria Genetics
  • CytoDyn Acquires Advanced Genetic Technologies
  • Takeda Europe to Take Over Paradigm Therapeutics
  • AmerisourceBergen Announces Acquisition of IgG of America
  • GlaxoSmithKline Plans Praecis Acquisition

9. RECENT INDUSTRY ACTIVITY

  • Eureka, Glycos Partner to Develop Bacterium for Biorefinery
  • Genzyme Acquires Rights to MabCampath, Fludara and Leukine
  • Quantel Announces Genetic Engineering Technology Support for Lasergraphics
  • USDA to Deregulate Syngenta' s GE Corn
  • Archer Daniels, Deere & Company and Monsanto to Form Partnership
  • Genzyme Collaborates with ICGEB
  • Veredus Partners with STMicroelectronics to Establish Bio-Application Lab
  • Invitrogen Gains License for Stem Cell Line
  • Millipore Enters into Agreement with Solabia
  • Advanced Cell Forms Joint Venture with CHA Biotech
  • Luminex Enters into Agreement with Mingyuan
  • ProGenTech Inks Agreement with Human Genetic Signatures
  • Monsanto and China National Seed Group Sign Agreement
  • Monsanto and Syngenta Sign Royalty-Bearing Licensing Agreement
  • Affymetrix Signs Definitive Agreement with Panomics
  • Sanofi-Aventis to Use Regeneron' s Genetic Modification Method
  • Monsanto to Build DEKALB Corn Seed Production Facility
  • Qatar Receives Grant to Augment Agro-Genetic Engineering Capacity
  • Monsanto Expands Jerseyville Facility
  • Sirtris Pharmaceuticals Obtains Approval for NamPRT
  • Origin Agritech Obtains License for Phytase Corn
  • Shenyang Xiehe Establishes Genetic Engineering Subsidiary
  • BioServe Enters into Alliance with DNAPrint Genomics
  • Evogene Teams Up with Ormat on Biodiesel
  • EMD and Dendritic Nanotechnologies Enter into License and Supply Agreement
  • AureoGen Biosciences Enters into Agreement with Takara Bio
  • Shanghai Wanxing Inks Agreement with Blue Blood Biotech
  • Stem Cell Sciences Signs Agreement with RIKEN Centre
  • Olympus and National Center for Biological Sciences Open New Facility
  • Biocentury Obtains Approval for Hybrid Cotton Seed in India
  • Novozymes to Expand Operation Base
  • Cell Therapeutics to Develop More Targeted Treatments for Cancer

10. PRODUCT/SERVICE LAUNCHES

  • Affymetrix Introduces MyGeneChip Program
  • Genomnz to Unveil DNA Testing Service
  • Whatman Introduces EasiCollect
  • Nanoxis Launches Membrane Protein
  • Few Important Terms Used in Genetic Engineering
  • Chromosomes
  • Genome
  • Recombinant DNA
  • Retroviruses
  • Plasmids
  • Transgenic Animals and Plants
  • Gene Therapy

GLOBAL DIRECTORY

Back to Top